Rchr
J-GLOBAL ID:200901016742240357
Update date: Sep. 10, 2022
Yoshimoto Jiro
ヨシモト ジロウ | Yoshimoto Jiro
Contact this researcher
You can send email directly to the researcher.
Affiliation and department:
Juntendo University School of Medicine, Hepatobiliary Pancreatic Surgery
About Juntendo University School of Medicine, Hepatobiliary Pancreatic Surgery
Search "Juntendo University School of Medicine, Hepatobiliary Pancreatic Surgery"
Detailed information
Research field (1):
Digestive surgery
Research keywords (4):
移植
, 肝癌
, Transplantation
, Hepatocelluler Carcinoma
Research theme for competitive and other funds (4):
移植免疫学
肝癌の増殖活性の検討
Transplantation Immunology
Proliferation activity of Hepatocelluler Carcinoma
MISC (6):
H Sugo, J Yoshimoto, K Kojima, S Futagawa. Surgical treatment for multicentric hepatocellular carcinomas according to clonality. HEPATOLOGY RESEARCH. 1998. 10. 2. 101-111
YOSHIMOTO Jiro, KITABATAKE Toshiaki, IWATA Toyohito, TAKAMORI Shigeru, WATANABE Shin, KOJIMA Kuniaki, FUKASAWA Masaki, BEPPU Tomoe, FUTAGAWA Shunji. Usefulness of p53 and c-myc Proteins as Prognostic Factors of Hepatocellular Carcinoma. Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons). 1998. 23. 5. 789-794
J Yoshimoto, T Iwata, S Takamori, K Kojima, S Futagawa. Usefulness of monoclonal antibody Ki-67 as a prognostic factor of hepatocellular carcinoma. INTERNATIONAL HEPATOLOGY COMMUNICATIONS. 1997. 6. 5. 209-218
肝切除後早期血管造形の有用性に関する検討(共著). 日本臨床外科学会雑誌. 1997. 58. 11. 33-39
門脈左亢追症手術後、肝癌発生危険因子の検討-MIB-1抗体を用いた免疫組織化学的染色による検討(共著). 日本門脈左亢進症食道静脈瘤学会雑誌. 1997. 3. 3. 233-239
more...
Education (4):
- 1997 Juntendo University
- 1997 Juntendo University Graduate School, Division of Medicine
- 1991 Juntendo University Faculty of Medicine
- 1991 Juntendo University Faculty of Medicine
Professional career (1):
(BLANK) (Juntendo University)
Association Membership(s) (5):
日本臨床外科学会
, 日本肝臓学会
, 日本消化器病学会
, 日本消化器外科学会
, 日本外科学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM